Are you eager to sharpen your clinical edge? Learn about revolutionary scientific findings that may inform your counsel on type 2 diabetes? Understand the practical applications for this emerging research?
Please join for a dynamic learning event entitled, “Gut Microbiome Modifications. A Novel Approach to Disease Management,” on November 2, 2021, 2–4 pm ET. Register Today! 2.0 level two CEUs/CPEUs have been requested from the Commission on Dietetic Registration. RDs/RDNs can apply the CPEUs to their continuing education requirement.
This session is one of a series of educational events sponsored by Pendulum Therapeutics. Don’t miss the unique learning opportunity. Register Today to learn from several leading experts in this field:
|
|
|
|
Kim Kelly, PharmD, FCCP, BCPS, CPC, CEC, CDTC |
Orville Kolterman, MD |
Virginia Valentine, APRN-CNS, BC-ADM, CDCES, FADCES |
Kristin Neusel, MS, RDN, LD, CDCES |
Kim Kelly, PharmD, FCCP, BCPS, CPC, CEC, CDTC
President, Kelly Diabetes Associates, LLC
Dr. Kelly is Board Certified in Pharmacotherapy, and his research and experience spans multiple publications, participation on editorial boards, journal review panels, and committee involvement with various professional organizations. He served as (among others) Director of the Metabolic Support Service at Truman Medical Center; President of the American College of Clinical Pharmacy (ACCP); Chairman of the Board of Directors of the ACCP Research Institute; and became a Fellow of the American College of Clinical Pharmacy in 1985. He is a Certified Diabetes Technology Clinician (DTS), a Certified Professional Coder (AAPC) and a Certified Endocrine Coder (AACE). Dr. Kelly additionally serves as faculty for Children with Diabetes and serves on the Board of Directors of the College Diabetes Network.
Orville Kolterman, MD
Chief Medical Officer, Pendulum Therapeutics
Dr. Kolterman is an internationally respected diabetes expert and has successfully brought four glucose-lowering pharmaceuticals from research trials to market. He also served as chief medical officer of Amylin Pharmaceuticals. Dr. Kolterman received both his MD and his endocrinology training at Stanford School of Medicine. He has been involved in diabetes care for nearly 50 years.
Virginia Valentine, APRN-CNS, BC-ADM, CDCES, FADCES
Diabetes Specialist, Clinical La Esperanza in Albuquerque
Ms. Valentine holds faculty appointments with the University of New Mexico and serves as clinician faculty for the endocrinology Project ECHO Clinic (Endo ECHO), which trains and supports primary care providers in rural and underserved communities to improve their knowledge and skill in endocrinology care. Ms. Valentine has provided professional education on a state, national, and international level. Her delivery always includes participation and instills a sense of confidence and willingness to try something new.
Kristin Neusel, MS, RDN, LD, CDCES
Senior Manager, Diabetes Education, and Patient Engagement, Pendulum Therapeutics
Ms. Neusel is the senior manager of nutrition programs and engagement at Pendulum Therapeutics. She leads a team of registered dietitians who are both customer and health-professional facing to drive education and awareness of Pendulum Glucose Control and the importance of diet to maintain a healthy gut microbiome. Before her role with Pendulum, Ms. Neusel was the Senior Clinical Educator for Aegerion Pharmaceuticals, focusing on glucose and lipid metabolism for people with rare and ultra-rare genetic diseases. During that time, she cultivated her passion for diabetes-focused therapeutics and became a CDCES. Neusel completed both her undergraduate and graduate degrees in Human Nutrition and Dietetics from Southern Illinois University.
|